Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 19, 2025, Regulus Therapeutics (RGLS) has a market cap of $0.14 billion USD. According to our data, Regulus Therapeutics is ranked No.7334 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 19, 2025 | $0.14 B |
31.86%
|
| Dec 31, 2024 | $0.10 B |
23.44%
|
| Dec 29, 2023 | $83.84 M |
-6.57%
|
| Dec 30, 2022 | $89.74 M |
-57.19%
|
| Dec 31, 2021 | $0.21 B |
-76.30%
|
| Dec 31, 2020 | $0.88 B |
51.69%
|
| Dec 31, 2019 | $0.58 B |
-4.30%
|
| Dec 31, 2018 | $0.61 B |
-92.55%
|
| Dec 29, 2017 | $8.17 B |
-53.78%
|
| Dec 30, 2016 | $17.69 B |
-74.20%
|
| Dec 31, 2015 | $68.54 B |
-45.64%
|
| Dec 31, 2014 | $126.07 B |
117.05%
|
| Dec 31, 2013 | $58.09 B |
17.30%
|
| Dec 31, 2012 | $49.52 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Ionis Pharmaceuticals
IONS
|
$4.51 B |
-0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$30.36 B |
0.000 M
|
USA
|
 Arrowhead Pharmaceuticals
ARWR
|
$1.54 B |
-0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$5.22 B |
0.000 M
|
USA
|
 Moderna
MRNA
|
$9.56 B |
-0.000 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.35 B |
0.000 M
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$125.74 B |
-0.003 M
|
USA
|
 Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
USA
|
 Amgen
AMGN
|
$149.09 B |
0.124 B
|
USA
|
 Biogen
BIIB
|
$17.36 B |
-0.001 M
|
USA
|
 CRISPR Therapeutics
CRSP
|
$3.26 B |
0.000 M
|
Switzerland
|
 Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
 Intellia Therapeutics
NTLA
|
$0.75 B |
-0.000 M
|
USA
|
 Sangamo Therapeutics
SGMO
|
$0.16 B |
-0.989 M
|
USA
|
| Market Cap | = | RGLS Stock Price | * | RGLS Shares Outstanding |
| = | $2.06 | * | 66.24 M | |
| = | $0.14 B |